KeyBank National Association
NAMS icon

KeyBank National Association’s NewAmsterdam Pharma NAMS Stock Holding History

KeyBank National Association’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$423K Hold
12,480
– – ﹤0.01% 996
2026
Q1 		$399K Sell
12,480
-619
-5% -$20.2K ﹤0.01% 912
2025
Q4 		$460K Sell
13,099
-2,915
-18% -$106K ﹤0.01% 847
2025
Q3 		$455K Buy
+16,014
New +$384K ﹤0.01% 830
2025
Q2 		– Sell
-9,983
Closed -$204K – 1188
2025
Q1 		$204K Hold
9,983
– – ﹤0.01% 1099
2024
Q4 		$257K Buy
+9,983
New +$212K ﹤0.01% 1038

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

KeyBank National Association's NAMS Position: Q2 2026 in Review

KeyBank National Association held its NewAmsterdam Pharma (NAMS) position steady in Q2 2026 at 12,480 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #996.

KeyBank National Association first reported a position in NAMS in Q4 2024 and has held it in 6 quarters since. The position peaked at $460K in Q4 2025. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • KeyBank National Association held 12,480 shares of NewAmsterdam Pharma worth $423K as of Q2 2026.
  • KeyBank National Association left its NewAmsterdam Pharma share count unchanged in Q2 2026.
  • NewAmsterdam Pharma made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #996 holding.
  • KeyBank National Association first reported a position in NewAmsterdam Pharma in Q4 2024 and has held it in 6 quarters since.
  • KeyBank National Association's NewAmsterdam Pharma position peaked at $460K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.